About PHARMCUBE

By leveraging data across the full life-cycle of pharmaceutical

products plus scalable and highly compatible AI technology,

we serve the users with our data, media and consulting

services and teams consisting of medical and pharmaceutical

professionals, promoting the innovation and business model

transformation in the industry to help users achieve success

faster.

By leveraging data across the full life-cycle of pharmaceutical products plus scalable and highly compatible AI technology, we serve the users with our data, media and consulting services and teams consisting of medical and pharmaceutical professionals, promoting the innovation and business model transformation in the industry to help users achieve success faster.

PHARMCUBE Data

Based on AI, we have built an exclusive data

standardizing system to integrate data across

the entire pharmaceutical industry chain, including

investment and financing, patent application

landscape, market competition, clinical research,

registration and approval, market access, sales, and

evidence-based medicine. For every professional in

the industry, there is always one database for you.

Based on AI, we have built an exclusive data standardizing system to integrate data across the entire pharmaceutical industry chain, including investment and financing, patent application landscape, market competition, clinical research, registration and approval, market access, sales, and evidence-based medicine. For every professional in the industry, there is always one database for you.

Every day, we provide quality content ranging from

global new drug R&D progress, investment and

financing news, interpretation of China's healthcare

policies, to the prediction of the industry's

development trend. Services such as medical

visualization, webinars, events are also our forte. We

have continuously delivered insights to over

800,000 specialized readers and more than 300

companies, extending our influence to professionals

including pharmaceutical R&D, marketing, BD

personnel and investors.

Every day, we provide quality content ranging from global new drug R&D progress, investment and financing news, interpretation of China's healthcare policies, to the prediction of the industry's development trend. Services such as medical visualization, webinars, events are also our forte. We have continuously delivered insights to over 800,000 specialized readers and more than 300 companies, extending our influence to professionals including pharmaceutical R&D, marketing, BD personnel and investors.

Based on our powerful data, PHARMCUBE

continuously tracks and researches the

pharmaceutical industry to help clients discover

opportunities and formulate strategies. We offer

well-rounded decision-making assistance through

six consulting services: competition landscape and

development planning, clinical evaluation and

promotion strategy, market potential assessment

and valuation, product pipeline screening and

planning, pricing and market access policies, and

industry and competitor research.

Based on our powerful data, PHARMCUBE continuously tracks and researches the pharmaceutical industry to help clients discover opportunities and formulate strategies. We offer well-rounded decision-making assistance through six consulting services: competition landscape and development planning, clinical evaluation and promotion strategy, market potential assessment and valuation, product pipeline screening and planning, pricing and market access policies, and industry and competitor research.

Our Clients

Clients from 1000+ pharmaceutical companies and investment institutions are using
PHARMCUBE's products and services.

Latest Reports

Based on our adequate data assets, PHARMCUBE continuously produces research and value across the entire pharmaceutical industry chain.

中国创新药企发展白皮书(2022年)
2022年12月
本白皮书由医药魔方和毕马威共同编制并发布,全文共分为三个章节,分别从创新药企的起航、困境与突破三个维度描绘了当下中国创新药企发展的各阶段历程
Topic:数字化转型创新药企商业化新药研发
精选
中国医药行业十大趋势总结(2021年)
2022年03月
深度总结与分析每年中国医药行业的十大发展趋势
Topic:产业政策发展趋势市场分析
精选
2021年医药魔方转化医学TOP25靶点报告
2022年01月
基于NextPharma转化医学数据,每年会遴选出一批取得重大突破的25个靶点,蕴藏了当前一整年研发投资的全新机会
Topic:新药研发靶点研究
精选

Unlock Our Services Now

Empower biopharma innovation

Accelerate decision-making

欢迎扫码咨询产品&服务
电话:010-64736966